NCT00180505 - ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

October 31, 2009

Conditions

Peripheral Vascular Diseases

Interventions

DEVICE

ABSOLUTE™: Self-Expandable Peripheral Nitinol Stent

A prospective, non-randomized, multi-center study to investigate the performance of the ABSOLUTE™ .035 Peripheral Self-Expanding Stent System (ABSOLUTE™ Stent) in preventing restenosis of occluded or stenotic superficial femoral or proximal popliteal arteries. Follow up at 30, 180, 270, 365 days and 2 years.

Trial Locations (13)

1090

Allgemeines Krankenhaus der Stadt Wien (AKH Wien), Vienna

5000

CHR de Namur, Namur

9026

Landeskrankenhaus Klagenfurt, Klagenfurt

20014

Hospital de Donostia, Donostia / San Sebastian

22527

Universitäres Herz & Gefässzentrum Hamburg, Hamburg

27100

Policlinico San Matteo, Pavia

35033

Hôpital Pontchaillou- CHU, Rennes

41100

Nuovo Ospedale Civile Sant' Agostino, Baggiovara (Modena)

54270

Polyclinique Louis Pasteur, Essey-lès-Nancy

57001

Papageorgiou Hospital, Thessaloniki

79189

Herzzentrum Bad Krozingen, Bad Krozingen

83013

Casa di Cura Montevergine, Mercogliano

04289

Herzzentrum Leipzig, Leipzig